Clear all

Boccalini C., Dodich A., Scheffler M., Laganà V., Fratto E., Frisoni G. B., Bruni A. C., Colao R., Perani D., Garibotto V.. In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1 Met146Leu Pathogenic Variant - Neurology, 103(13): , 24 December 2024

Collij L. E., Bollack A., La Joie R., Shekari M., Bullich S., Roé-Vellvé N., Koglin N., Jovalekic A., Garciá D. V., Drzezga A., Garibotto V., Stephens A. W., Battle M., Buckley C., Barkhof F., Farrar G., Gispert J. D.. Centiloid recommendations for clinical context-of-use from the AMYPAD consortium - Alzheimer's & Dementia, 20(12): 9037-9048, 20 November 2024

Pievani M., Ribaldi F., Toussas K., Da Costa S., Jorge J., Reynaud O., Chicherio C., Blouin J. L., Scheffler M., Garibotto V., Jovicich J., Jelescu I. O., Frisoni G. B.. Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study - Neurobiology of Aging, 144: 104-113, 20 September 2024

Stampacchia S., Asadi S., Tomczyk S., Ribaldi F., Scheffler M., Lövblad K. O., Pievani M., Fall A. B., Preti M. G., Unschuld P. G., Van De Ville D., Blanke O., Frisoni G. B., Garibotto V., Amico E.. Fingerprints of brain disease: connectome identifiability in Alzheimer’s disease - Communications Biology, 7: 1169, 18 September 2024

Goldman J. P., Jané P., Zaghir J., Pirazzo Andrade Teixeira E., Peretti D. E., Garibotto V., Lovis C.. Automatic Classification of Conclusions from Multi-Tracer Reports of PET Brain Imaging in Cognitive Impairment - Studies in Health Technology and Informatics, 316: 560-564, 22 August 2024

Mansouri Z., Salimi Y., Hajianfar G., Wolf N. B., Knappe L., Xhepa G., Gleyzolle A., Ricoeur A., Garibotto V., Mainta I., Zaidi H.. The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT: a preliminary machine learning study - European Journal of Nuclear Medicine and Molecular Imaging, 51(13): 4111-4126, 09 July 2024

Peretti D. E., Boccalini C., Ribaldi F., Scheffler M., Marizzoni M., Ashton N. J., Zetterberg H., Blennow K., Frisoni G. B., Garibotto V.. Association of glial fibrillary acid protein, Alzheimer’s disease pathology and cognitive decline - Brain, 147(12): 4094-4104, 28 June 2024

Sanaat A., Boccalini C., Mathoux G., Perani D., Frisoni G. B., Haller S., Montandon M. L., Rodriguez C., Giannakopoulos P., Garibotto V., Zaidi H.. A deep learning model for generating [18F]FDG PET Images from early-phase [18F]Florbetapir and [18F]Flutemetamol PET images - European Journal of Nuclear Medicine and Molecular Imaging, 51(12): 3518-3531, 11 June 2024

Groot C., Smith R., Collij L. E., Mastenbroek S. E., Stomrud E., Binette A. P., Leuzy A., Palmqvist S., Mattsson-Carlgren N., Strandberg O., Cho H., Lyoo C. H., Frisoni G. B., Peretti D. E., Garibotto V., La Joie R., Soleimani-Meigooni D. N., Rabinovici G., Ossenkoppele R., Hansson O.. Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment - JAMA Neurology, 81(8): 845-856, 10 June 2024

Ribaldi F., Palomo R., Altomare D., Scheffler M., Assal F., Ashton N. J., Zetterberg H., Blennow K., Abramowicz M., Garibotto V., Chicherio C., Frisoni G. B.. The Taxonomy of Subjective Cognitive Decline: Proposal and First Clinical Evidence from the Geneva Memory Clinic Cohort - Neurodegenerative Diseases, 24(1): 16–25, 22 May 2024

Mendes A. J., Ribaldi F., Lathuiliere A., Ashton N. J., Zetterberg H., Abramowicz M., Scheffler M., Assal F., Garibotto V., Blennow K., Frisoni G. B.. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients - Alzheimer's Research & Therapy, 16: 110, 16 May 2024

Nencha U., Rigoni I., Ribaldi F., Altomare D., Seeck M., Garibotto V., Vulliémoz S., Frisoni G. B.. Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer’s disease - Neurobiology of Aging, 139: 1-4, 3 April 2024

Boccalini C., Caminiti S. P., Chiti A., Frisoni G. B., Garibotto V., Perani D., Alzheimer's Disease Neuroimaging Initiative.. The diagnostic and prognostic value of tau-PET in amnestic MCI with different FDG-PET subtypes - Annals of Clinical and Translational Neurology, 11(5): 1236-1249, 29 March 2024

Ceyzériat K., Jaques E., Gloria Y., Badina A., Millet P., Koutsouvelis N., Dipasquale G., Frisoni G. B., Zilli T., Garibotto V., Tournier B. B.. Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats - Journal of Alzheimer’s Disease, 98(3): 1001-1016, 12 March 2024

Frisoni G. B., Festari C., Massa F., Cotta Ramusino M., Orini S., Aarsland D., Agosta F., Babiloni C., Borroni B., Cappa S. F., Frederiksen K. S., Froelich L., Garibotto V. Haliassos A., Jessen F., Kamondi A., Kessels R. P., Morbelli S. D., O'Brien J. T., Otto M., Perret-Liaudet A., Pizzini F. B., Vandenbulcke M., Vanninen R., Verhey F., Vernooij M. W., Yousry T., Boada Rovira M., Dubois B., Georges J., Hansson O., Ritchie C. W., Scheltens P., van der Flier W. M,. Nobili F.. European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders - Lancet Neurology, 23(3): 302-312, March 2024

Caminiti S. P,. Galli A., Jonghi-Lavarini L., Boccalini C., Nicastro N., Chiti A., Garibotto V., Perani D.. Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies - Parkinsonism & Related Disorders, 122: 106061, 2 March 2024

Hönig M., Altomare D., Caprioglio C., Collij L., Barkhof F., Van Berckel B., Scheltens P., Farrar G., Battle M. R., Theis H., Giehl K., Bischof G. N., Garibotto V., Molinuevo J. L. L., Grau-Rivera O., Delrieu J., Payoux P., Demonet J. F., Nordberg A. K., Savitcheva I., Walker Z., Edison P., Stephens A. W., Gismondi R., Jessen F., Buckley C. J., Gispert J. D., Frisoni G. B., Drzezga A., AMYPAD Consortium.. Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease - Neurology, 102(6): , 20 February 2024

Mendes A. J., Ribaldi F., Lathuiliere A., Ashton N. J., Janelidze S., Zetterberg H., Scheffler M., Assal F., Garibotto V., Blennow K., Hansson O., Frisoni G. B.. Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort - Journal of Neurology, 271(4): 2053-2066, 09 January 2024

Mathoux G., Boccalini C., Peretti D. E., Arnone A., Ribaldi F., Scheffler M., Frisoni G. B., Garibotto V.. A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort - European Journal of Nuclear Medicine and Molecular Imaging, 51(6): 1639-1650, 6 January 2024

Mainta I. C., Neroladaki A., Wolf N. B., Benamran D., Boudabbous S., Zilli T., Garibotto V.. [68Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria - Journal of Nuclear Medicine, 65(9): 1376-1382, 3 September 2024

Caminiti SP, Boccalini C, Nicastro N, Garibotto V, Perani D. Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways - , : , February 2023

Caminiti SP, Boccalini C, Nicastro N, Garibotto V, Perani D. Sex differences in brain metabolic connectivity architecture in probable dementia with Lewy bodies - Neurobiology of Aging, 126: 14-24, February 2023

Caminiti SP, Boccalini C, Nicastro N, Garibotto V, Perani D. Alzheimer’s Disease neuroimaging initiative. Sex differences in brain metabolic connectivity architecture in probable dementia with Lewy bodies - , 126: 14-24, February 2023

Caprioglio C, Ribaldi F, Visser LNC, Minguillon C, Collij LE, Grau-Rivera O, Zeyen P, Molinuevo JL, Gispert JD, Garibotto V, Moro C, Walker Z, Edison P, Demonet JF, Barkhof F, Scheltens P, Alves IL, Gismondi R, Farrar G, Stephens AW, Jessen F, Frisoni GB, Altomare D. Analysis of psychological symptoms following disclosure of amyloid-positron emission tomography imaging results to adults with subjective cognitive decline - , 6(1): e2250921, January 2023

Ceyzériat K, Zilli T, Millet P, Koutsouvelis N, Dipasquale G, Fossey C, Cailly T, Fabis F, Frisoni GB, Garibotto V, Tournier BB. Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats - J Neuroinflammation, 19(1): 311, December 2022

Boccalini C, Carli G, Vanoli EG, Cocco A, Albanese A, Garibotto V, Perani D. Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease - , 9: 10737220, January 2023

Festari C, Massa F, Cotta Ramusino M, Gandolfo F, Nicolosi V, Orini S, Aarsland D, Agosta F, Babiloni C, Boada M, Borroni B. Cappa S, Dubois B, Frederiksen KS, Froelich L, Garibotto V, Georges J, Haliassos A, Hansson O, Jessen F, Kamondi A, Kessels RPC, Morbelli S, O’Brien JT, Otto M, Perret-Liaudet A, Pizzini FB, Ritchie CW, Scheltens P, Vandenbulcke M, Vanninen R, Verhey F, Vernooij MW, Yousry T, Van Der Flier WM, Nobili F, Frisoni GB. European consensus for the diagnosis of MCI and mild dementia: Preparatory phase - Alzheimer's & Dementia, : 1-13, October 2022

Treglia G, Piccardo A, Garibotto V. [18F] FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street? - Clinical Autonomic Research, 32(6): 399-401, December 2022

Evangelista L, Pietrzak A, Ekmekcioglu O, Ovcaricek PP, Ambrosini V, Balogova S, Cunha L, Eccles A, Garibotto V, Lewington V, Israel O, Kunikowska J. Gender issues in the nuclear medicine community: results from a survey promoted by the EANM Women Empowerment Task Force - Eur J Nucl Med Mol Imaging, 9: 10737220, June 2022